MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
163 hedge funds and large institutions have $1.35B invested in Momenta Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 51 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 166 → 163 (-3)
Holders
163
Holding in Top 10
–
Calls
$2.78M
Puts
$602K
Top Buyers
| 1 | +$34M | |
| 2 | +$18M | |
| 3 | +$10.4M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$9.07M |
| 5 |
VMI
VHCP Management II
New York
|
+$7.71M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$23.3M | |
| 3 | -$15.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.02M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.88M |